Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Hyperferritinemia after adult allogeneic hematopoietic cell transplantation: quantification of iron burden by determining non-transferrin-bound iron.

Goto T, Ikuta K, Inamoto Y, Kamoshita S, Yokohata E, Koyama D, Onodera K, Seto A, Watanabe K, Imahashi N, Tsukamoto S, Ozawa Y, Sasaki K, Ito M, Kohgo Y, Miyamura K.

Int J Hematol. 2013 Jan;97(1):125-34. doi: 10.1007/s12185-012-1252-1. Epub 2012 Dec 23.

PMID:
23264147
2.

Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy.

Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A.

Biol Blood Marrow Transplant. 2010 Jan;16(1):115-22. doi: 10.1016/j.bbmt.2009.09.011. Epub 2009 Sep 18.

3.

High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors.

Majhail NS, DeFor T, Lazarus HM, Burns LJ.

Biol Blood Marrow Transplant. 2008 Jul;14(7):790-4. doi: 10.1016/j.bbmt.2008.04.009.

4.

A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors.

Majhail NS, Lazarus HM, Burns LJ.

Biol Blood Marrow Transplant. 2010 Jun;16(6):832-7. doi: 10.1016/j.bbmt.2010.01.004. Epub 2010 Jan 14.

5.

Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation.

Sivgin S, Baldane S, Kaynar L, Kurnaz F, Pala C, Ozturk A, Cetin M, Unal A, Eser B.

Neoplasma. 2012;59(2):183-90.

PMID:
22248276
6.

Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation.

Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Yağci M.

Transplant Proc. 2010 Jun;42(5):1841-8. doi: 10.1016/j.transproceed.2009.11.049.

PMID:
20620535
7.
8.

Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation.

Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ.

Bone Marrow Transplant. 2008 Dec;42(12):799-805. doi: 10.1038/bmt.2008.262. Epub 2008 Sep 1.

PMID:
18762767
9.

Iron overload in survivors of childhood leukemia after allogeneic hematopoietic stem cell transplantation.

Chotsampancharoen T, Gan K, Kasow KA, Barfield RC, Hale GA, Leung W.

Pediatr Transplant. 2009 May;13(3):348-52. doi: 10.1111/j.1399-3046.2008.00983.x. Epub 2008 Jun 1.

PMID:
18518909
10.

Prognostic impact of posttransplantation iron overload after allogeneic stem cell transplantation.

Meyer SC, O'Meara A, Buser AS, Tichelli A, Passweg JR, Stern M.

Biol Blood Marrow Transplant. 2013 Mar;19(3):440-4. doi: 10.1016/j.bbmt.2012.10.012. Epub 2012 Oct 23.

11.

Association between Plasma Endothelin-1, Transforming Growth Factor-β, Fibroblast Growth Factor, and Nitric Oxide Levels and Liver Injury in Hematopoietic Stem Cell Transplantation Recipients with Persistent Iron Overload after Transplantation.

Akı ŞZ, Suyanı E, Cengiz M, Özenirler S, Elbeğ Ş, Paşaoğlu H, Sucak GT.

Biol Blood Marrow Transplant. 2015 May;21(5):948-53. doi: 10.1016/j.bbmt.2015.02.002. Epub 2015 Feb 11.

12.

Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia.

Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MD.

Br J Haematol. 2009 Sep;146(5):569-72. doi: 10.1111/j.1365-2141.2009.07810.x. Epub 2009 Jul 13.

PMID:
19604239
13.

Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN.

Biol Blood Marrow Transplant. 2006 May;12(5):506-10.

14.

Non-transferrin-bound iron and hepatic dysfunction in African dietary iron overload.

McNamara L, MacPhail AP, Mandishona E, Bloom P, Paterson AC, Rouault TA, Gordeuk VR.

J Gastroenterol Hepatol. 1999 Feb;14(2):126-32.

PMID:
10029292
15.

Transfusion-associated iron overload as an adverse risk factor for transplantation outcome in patients undergoing reduced-intensity stem cell transplantation for myeloid malignancies.

Kim YR, Kim JS, Cheong JW, Song JW, Min YH.

Acta Haematol. 2008;120(3):182-9. doi: 10.1159/000187646. Epub 2009 Jan 5.

PMID:
19129689
16.

Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation.

Brissot E, Savani BN, Mohty M.

Semin Hematol. 2012 Jan;49(1):35-42. doi: 10.1053/j.seminhematol.2011.10.003. Review.

PMID:
22221783
17.

Impact of pretransplant serum ferritin level on risk of invasive mold infection after allogeneic hematopoietic stem cell transplantation.

Dadwal SS, Tegtmeier B, Liu X, Frankel P, Ito J, Forman SJ, Pullarkat V.

Eur J Haematol. 2015 Mar;94(3):235-42. doi: 10.1111/ejh.12421. Epub 2014 Sep 13.

PMID:
25082161
18.

Iron overload in allogeneic hematopoietic cell transplantation outcome: a meta-analysis.

Armand P, Kim HT, Virtanen JM, Parkkola RK, Itälä-Remes MA, Majhail NS, Burns LJ, DeFor T, Trottier B, Platzbecker U, Antin JH, Wermke M.

Biol Blood Marrow Transplant. 2014 Aug;20(8):1248-51. doi: 10.1016/j.bbmt.2014.04.024. Epub 2014 Apr 24.

19.

Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease.

Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher AT.

Eur J Haematol. 2009 Dec 1;83(6):565-71. doi: 10.1111/j.1600-0609.2009.01345.x. Epub 2009 Sep 8.

PMID:
19737308
20.

Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation.

Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M.

Biol Blood Marrow Transplant. 2009 Feb;15(2):195-204. doi: 10.1016/j.bbmt.2008.11.012.

Supplemental Content

Support Center